0% found this document useful (0 votes)
22 views34 pages

Understanding Diabetes Types and Symptoms

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to insufficient insulin production or action, leading to various complications. It includes several types such as Type 1, Type 2, gestational diabetes, and others, each with distinct causes and treatment approaches. Effective management involves lifestyle modifications, medication, and regular monitoring to prevent acute and chronic complications.

Uploaded by

950322105011
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
22 views34 pages

Understanding Diabetes Types and Symptoms

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to insufficient insulin production or action, leading to various complications. It includes several types such as Type 1, Type 2, gestational diabetes, and others, each with distinct causes and treatment approaches. Effective management involves lifestyle modifications, medication, and regular monitoring to prevent acute and chronic complications.

Uploaded by

950322105011
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

UNIT 4

DIABETES & OBESITY

Introduction to Diabetes Mellitus:

Diabetes is a long-term metabolic disorder marked by persistently high


levels of blood glucose (blood sugar). Over time, this elevated glucose can cause
severe complications affecting the heart, blood vessels, eyes, kidneys, and
nerves.

Diabetes mellitus (DM) refers to a group of metabolic disorders in which


the body fails to properly regulate blood glucose levels. This condition arises
due to either insufficient insulin production, impaired insulin action, or both.
Diabetes mellitus is broadly classified into several types, including Type 1
diabetes, Type 2 diabetes, maturity-onset diabetes of the young (MODY),
gestational diabetes, neonatal diabetes, and steroid-induced diabetes.

What is diabetes mellitus?

Diabetes is a condition that occurs when the level of sugar (glucose) in


your blood becomes too high. It develops either because the pancreas doesn’t
produce enough insulin—or any at all—or because the body doesn’t respond
properly to insulin’s effects. People of all ages can be affected by diabetes. Most
types of diabetes are long-term (chronic) conditions, but they can be effectively
managed through medication and/or lifestyle modifications.

Glucose, which mainly comes from the carbohydrates in food and drinks,
serves as the body’s primary source of energy. It travels through the
bloodstream to reach the body’s cells, where it is used for energy production.
However, glucose requires insulin—a hormone that acts like a “key”—to enter
these cells. When the pancreas fails to produce sufficient insulin, or when the
body becomes resistant to it, glucose remains in the bloodstream, leading to
high blood sugar (hyperglycemia).
Persistent high blood glucose levels over time can lead to serious health
complications, including heart disease, nerve damage, and vision problems.

The medical term for diabetes is diabetes mellitus. Another rare


condition, diabetes insipidus, shares part of the name but is entirely different.
Both conditions cause increased thirst and frequent urination, which is why
they share the term “diabetes.”

Types of Diabetes

There are several forms of diabetes, each with distinct causes and
characteristics. The most common types include:

1. Type 2 Diabetes:

Definition

Type 2 diabetes is characterized by insulin resistance combined with a relative


deficiency in insulin secretion. It is the most common form of diabetes.

Pathophysiology

 Insulin resistance: Tissues (muscles, fat, liver) fail to respond properly


to insulin.

 β-cell dysfunction: Progressive decline in insulin secretion over time.

 Contributing factors: Obesity, sedentary lifestyle, genetic


predisposition, poor diet, and hormonal imbalances.

Clinical Features

 Slow and often asymptomatic onset.

 Symptoms similar to Type 1 but usually milder:

o Fatigue

o Blurred vision
o Recurrent infections (especially skin and urinary tract)

o Slow-healing wounds

 Often diagnosed incidentally during routine checkups.

Complications

 Long-term hyperglycemia leads to:

o Microvascular complications: Retinopathy, nephropathy,


neuropathy

o Macrovascular complications: Coronary artery disease, stroke,


peripheral arterial disease

Treatment

 Lifestyle modification: Diet, exercise, weight management

 Oral hypoglycemic agents: Metformin, sulfonylureas, DPP-4 inhibitors,


SGLT2 inhibitors

 Insulin therapy: In advanced stages

2. Prediabetes: Prediabetes is a condition where blood glucose levels are


higher than normal but not high enough to be classified as Type 2 diabetes. It
represents an early warning stage that, if not managed through lifestyle
changes, can progress to full diabetes.

3. Type 1 Diabetes:

Definition

Type 1 diabetes is an autoimmune condition where the body’s immune system


destroys the insulin-producing β-cells in the pancreas, leading to an absolute
deficiency of insulin.
Pathophysiology

 Immune-mediated destruction of β-cells (autoantibodies against islet


cells, insulin, GAD65, etc.)

 Leads to absolute insulin deficiency

 Typically manifests in childhood or adolescence but can occur at any age

Clinical Features

 Rapid onset of symptoms:

o Polyuria (frequent urination)

o Polydipsia (increased thirst)

o Polyphagia (increased hunger)

o Unexplained weight loss

o Fatigue and weakness

 In severe cases, Diabetic Ketoacidosis (DKA) may develop,


characterized by vomiting, abdominal pain, fruity odor in breath, and
deep labored breathing (Kussmaul respiration)

Treatment

 Insulin therapy (essential for survival)

 Dietary management

 Regular blood glucose monitoring

 Education on DKA prevention

4. Gestational Diabetes:

Definition
Gestational diabetes is glucose intolerance first recognized during pregnancy,
usually in the second or third trimester.

Pathophysiology

 Pregnancy hormones (like human placental lactogen, progesterone, and


cortisol) cause insulin resistance.

 The pancreas compensates by producing more insulin; if it fails,


hyperglycemia occurs.

Risk Factors

 Obesity, family history of diabetes, previous GDM, polycystic ovary


syndrome (PCOS), older maternal age.

Complications

 For mother: High risk of Type 2 diabetes later in life.

 For baby: Macrosomia (large baby), hypoglycemia after birth, respiratory


distress, increased risk of obesity and diabetes in adulthood.

Treatment

 Dietary management

 Regular glucose monitoring

 Insulin therapy if necessary

 Postpartum follow-up for glucose tolerance

Other, less common forms of diabetes include:

5. Type 3c Diabetes: This occurs when the pancreas is damaged by conditions


such as pancreatitis, pancreatic cancer, cystic fibrosis, or hemochromatosis,
reducing its ability to produce insulin. Surgical removal of the pancreas
(pancreatectomy) can also cause Type 3c diabetes.

6. Latent Autoimmune Diabetes in Adults (LADA): LADA is similar to Type 1


diabetes but progresses more slowly. It results from an autoimmune attack on
pancreatic cells but typically develops in adults over 30 years of age.

7. Maturity-Onset Diabetes of the Young (MODY): Also known as monogenic


diabetes, MODY is caused by inherited gene mutations that affect insulin
production and function. There are more than 10 identified types of MODY,
and it often runs in families, accounting for up to 5% of all diabetes cases.

8. Neonatal Diabetes: A rare genetic form of diabetes that appears within the
first six months of life. About half of affected infants have permanent neonatal
diabetes mellitus, which lasts for life, while the rest have transient neonatal
diabetes mellitus, which disappears after a few months but may return later in
life.

9. Brittle Diabetes: A severe and unstable form of Type 1 diabetes


characterized by frequent, unpredictable swings between high and low blood
sugar levels. This instability often requires hospitalization, and in rare cases, a
pancreas transplant may be considered for permanent management.

How Common Is Diabetes?

Diabetes is a widespread condition affecting millions of people worldwide.


In the United States alone, around 37.3 million individuals—approximately
11% of the population—are living with diabetes. Among these cases, Type 2
diabetes is the most prevalent, accounting for 90% to 95% of all diagnoses.

Globally, an estimated 537 million adults are affected by diabetes.


Health experts project that this number will increase significantly, reaching
643 million by 2030 and 783 million by 2045, highlighting the growing
global burden of the disease.
What Are the Symptoms of Diabetes?

Common symptoms of diabetes include:

 Excessive thirst (polydipsia) and a dry mouth

 Frequent urination

 Persistent fatigue or tiredness

 Blurred vision

 Unexplained weight loss

 Numbness or tingling sensations in the hands or feet

 Slow-healing wounds, cuts, or sores

 Recurrent skin or vaginal yeast infections

If you or your child experience any of these symptoms, it is important to


consult a healthcare provider for evaluation and testing.

Symptoms by Type of Diabetes:

 Type 1 Diabetes (T1D): Symptoms often appear suddenly, developing


over a few weeks or months. In some cases, individuals may experience
signs of a serious complication known as diabetes-related ketoacidosis
(DKA), which requires urgent medical attention. DKA symptoms include
nausea or vomiting, abdominal pain, fruity-smelling breath, and rapid or
labored breathing.

 Type 2 Diabetes and Prediabetes: Symptoms may develop gradually or


be so mild that they go unnoticed. Some individuals may have no
obvious symptoms, and elevated blood sugar levels are often detected
through routine blood tests. A possible early indicator of prediabetes is
acanthosis nigricans, a condition that causes darkened, velvety patches
of skin, typically on the neck, armpits, or groin.

 Gestational Diabetes: This form of diabetes usually causes no


noticeable symptoms. It is typically detected through routine screening
tests conducted between 24 and 28 weeks of pregnancy.

What Causes Diabetes?

Diabetes develops when there is an excess of glucose (sugar) in the


bloodstream. Although elevated blood sugar is a common factor across all types
of diabetes, the underlying causes vary depending on the type.

The main causes of diabetes include:

 Insulin Resistance: The leading cause of Type 2 diabetes is insulin


resistance, which occurs when the body’s cells—particularly in the
muscles, fat, and liver—do not respond effectively to insulin. As a result,
glucose cannot enter the cells and remains in the bloodstream. Factors
that contribute to insulin resistance include obesity, poor diet, physical
inactivity, hormonal imbalances, genetics, and certain medications.

 Autoimmune Reaction: Type 1 diabetes and Latent Autoimmune


Diabetes in Adults (LADA) occur when the immune system mistakenly
attacks and destroys the insulin-producing beta cells in the pancreas,
leading to little or no insulin production.

 Hormonal Imbalances: During pregnancy, hormones released by the


placenta can cause insulin resistance. If the pancreas cannot produce
enough insulin to counter this resistance, gestational diabetes
develops. Other hormonal disorders, such as acromegaly and Cushing’s
syndrome, can also contribute to insulin resistance and the onset of
Type 2 diabetes.
 Pancreatic Damage: Damage to the pancreas due to disease, injury, or
surgery can impair its ability to produce insulin, leading to Type 3c
diabetes. Conditions such as pancreatitis, pancreatic cancer, or cystic
fibrosis may cause such damage.

 Genetic Mutations: Inherited or spontaneous genetic mutations can


lead to forms of diabetes such as Maturity-Onset Diabetes of the
Young (MODY) and Neonatal Diabetes.

Additionally, long-term use of certain medications, including corticosteroids


and some antiretroviral drugs used for HIV/AIDS treatment, can increase the
risk of developing Type 2 diabetes.

Complications of Diabetes

Diabetes can lead to both acute (sudden and severe) and chronic (long-
term) complications, primarily resulting from uncontrolled or prolonged high
blood sugar levels. Effective management of diabetes is essential to prevent or
delay these complications.

1. Acute Complications

These are serious, potentially life-threatening conditions that develop


rapidly and require immediate medical attention.

a) Hyperosmolar Hyperglycemic State (HHS):

 Occurs mostly in people with Type 2 diabetes.

 Results from extremely high blood glucose levels (above 600 mg/dL)
persisting for a long time.

 Leads to severe dehydration, confusion, and in severe cases, coma.

 Requires urgent medical treatment and fluid replacement.

b) Diabetic Ketoacidosis (DKA):


 Commonly affects individuals with Type 1 diabetes or undiagnosed
diabetes.

 Develops when the body lacks sufficient insulin to use glucose for
energy, causing it to break down fat instead.

 This process produces ketones, which accumulate in the blood, making


it acidic.

 Symptoms include rapid breathing, nausea, vomiting, abdominal pain,


and fruity-smelling breath.

 DKA is a medical emergency requiring immediate insulin and fluid


therapy.

c) Severe Hypoglycemia (Low Blood Sugar):

 Occurs when blood glucose levels drop below the normal range.

 Common in people using insulin or certain oral diabetes medications.

 Symptoms include blurred or double vision, confusion, clumsiness,


seizures, and in severe cases, loss of consciousness.

 Treatment involves emergency glucagon administration or prompt


medical attention.

2. Long-Term (Chronic) Complications

Long-term complications arise when high blood glucose levels persist


over time, leading to damage in blood vessels and nerves throughout the body.

a) Cardiovascular Complications:

Cardiovascular disease is the most common long-term complication of


diabetes. It includes:

 Coronary artery disease (CAD)


 Heart attack (myocardial infarction)

 Stroke (cerebrovascular accident)

 Atherosclerosis (hardening and narrowing of arteries)

b) Nerve Damage (Neuropathy):

 High glucose levels damage nerves, especially in the extremities.

 Causes numbness, tingling, pain, or loss of sensation, particularly in


the feet and hands.

c) Kidney Damage (Nephropathy):

 Persistent hyperglycemia damages the kidneys’ filtering units.

 Can lead to chronic kidney disease, renal failure, or the need for
dialysis or kidney transplantation.

d) Eye Damage (Retinopathy):

 Affects the blood vessels in the retina, leading to blurred vision, vision
loss, or blindness.

 May also cause glaucoma and cataracts.

e) Foot Problems:

 Reduced blood flow and nerve damage increase the risk of ulcers,
infections, and gangrene, sometimes leading to amputation.

f) Skin Conditions:

 People with diabetes are more prone to bacterial and fungal infections,
as well as slow-healing wounds.

g) Sexual Dysfunction:
 Nerve and blood vessel damage can lead to erectile dysfunction in men
and vaginal dryness or decreased sensation in women.

h) Digestive Issues (Gastroparesis):

 Nerve damage affecting the stomach muscles can delay emptying of food,
leading to nausea, vomiting, and bloating.

i) Hearing Loss:

 Diabetes is linked to an increased risk of hearing impairment due to


nerve and blood vessel damage in the auditory system.

j) Oral Health Problems:

 Increases the likelihood of gum (periodontal) disease, tooth decay, and


dry mouth.

3. Mental Health Impact

Living with diabetes can also significantly affect mental well-being.


Studies show that people with diabetes are two to three times more likely to
experience depression or anxiety compared to those without diabetes.
Psychological support is an important part of comprehensive diabetes
management.

How Is Diabetes Diagnosed?

Healthcare professionals diagnose diabetes by measuring the amount of


glucose (sugar) in your blood through specific blood tests. There are three
primary tests used to assess blood glucose levels:

1. Fasting Blood Glucose Test:

o For this test, you must fast for at least eight hours, consuming
only water before the test.
o Since eating affects blood sugar levels, this test helps determine
your baseline (fasting) glucose level.

2. Random Blood Glucose Test:

o This test can be performed at any time of the day, regardless of


when you last ate.

o It provides a quick snapshot of your current blood sugar level.

3. Hemoglobin A1c (HbA1c or Glycated Hemoglobin) Test:

o This test measures your average blood glucose levels over the
past two to three months.

o It is useful for both diagnosing diabetes and monitoring long-term


glucose control.

For gestational diabetes, which occurs during pregnancy, healthcare


providers use an Oral Glucose Tolerance Test (OGTT). This involves drinking
a glucose solution, after which blood samples are taken at specific intervals to
assess how well your body processes sugar.

How Is Diabetes Managed?

Managing diabetes is a multifaceted process that requires a personalized


approach since the condition affects each person differently. Effective diabetes
management focuses on maintaining healthy blood sugar levels and reducing
the risk of complications through lifestyle changes and, when necessary,
medication.

The four key components of diabetes management include:

1. Blood Sugar Monitoring


Regularly checking blood glucose levels is essential to evaluate how well
your treatment plan is working and to make necessary adjustments.
Monitoring can be done using:

 A glucose meter (via finger-stick testing)

 A continuous glucose monitor (CGM) for real-time tracking

Your healthcare provider will help determine your target blood glucose
range, and frequent monitoring will guide your daily management decisions
regarding diet, activity, and medication.

2. Oral Diabetes Medications

For people with Type 2 diabetes or prediabetes, oral medications help


regulate blood sugar levels when the body still produces some insulin.

 Metformin is the most commonly prescribed oral medication.

 Other classes of drugs may also be used depending on individual needs.


In certain cases, people with gestational diabetes may also require oral
medications to manage their blood sugar.

3. Insulin Therapy

Individuals with Type 1 diabetes must take synthetic insulin to survive


since their bodies produce little or no insulin. Some people with Type 2
diabetes may also need insulin if oral medications aren’t sufficient.
There are different types of insulin that vary in how quickly they start to work
and how long they last in the body.
Insulin can be administered through:

 Syringes (injections)

 Insulin pens

 Insulin pumps
 Rapid-acting inhaled insulin

4. Diet and Nutrition

Diet plays a vital role in blood sugar management.

 Meal planning and making healthy food choices help control glucose
levels.

 For those using insulin, carbohydrate counting is important since the


amount of carbs consumed determines the required insulin dose.

 A balanced diet rich in whole grains, vegetables, lean proteins, and


healthy fats supports weight control and lowers the risk of heart disease.

5. Physical Activity

Regular exercise improves insulin sensitivity, helping the body use insulin
more effectively and reducing insulin resistance.

 Activities such as walking, cycling, swimming, or strength training can


help manage blood sugar levels.

 Aim for at least 150 minutes of moderate-intensity activity per week,


as recommended by healthcare professionals.

Blood Glucose Regulation

1. Introduction

Glucose (C₆H₁₂O₆) is the main metabolic fuel of the human body and the
primary source of energy for most cells. Maintaining the concentration of
glucose in the blood within a narrow range is essential for survival and
optimal physiological functioning.

 The brain, red blood cells (RBCs), renal medulla, and retina depend
almost exclusively on glucose as their energy source.
 The normal fasting blood glucose level is typically between 70 and 100
mg/dL (3.9–5.6 mmol/L).

 After meals, glucose levels rise but usually do not exceed 140 mg/dL
(7.8 mmol/L) in healthy individuals.

The regulation of blood glucose involves a complex interplay between


hormonal, neural, and metabolic mechanisms, primarily mediated by the
pancreas, liver, muscles, and adipose tissue.

2. Significance of Blood Glucose Regulation

Maintaining blood glucose homeostasis ensures:

 Continuous energy supply to glucose-dependent organs (especially the


brain).

 Prevention of hypoglycemia (low glucose), which can lead to confusion,


seizures, coma, or death.

 Prevention of hyperglycemia (high glucose), which causes long-term


complications such as retinopathy, nephropathy, neuropathy, and
cardiovascular disease.

Thus, glucose homeostasis is critical for both immediate survival and long-
term health.

3. Sources and Fates of Blood Glucose

A. Sources of Blood Glucose

1. Dietary intake – absorption of carbohydrates (glucose, fructose,


galactose) through intestinal mucosa.

2. Glycogenolysis – breakdown of glycogen (in liver) into glucose during


fasting.
3. Gluconeogenesis – synthesis of glucose from non-carbohydrate sources
such as:

o Amino acids (alanine, glutamine)

o Lactic acid (from anaerobic glycolysis)

o Glycerol (from fat breakdown)

B. Utilization and Storage of Glucose

 Oxidation: Through glycolysis, the Krebs cycle, and oxidative


phosphorylation to yield ATP.

 Glycogenesis: Conversion of glucose into glycogen for storage (liver and


muscles).

 Lipogenesis: Excess glucose converted into fatty acids and stored as


triglycerides in adipose tissue.

 Conversion to non-essential amino acids in the liver.

4. Major Organs Involved in Glucose Homeostasis

a) Liver

 Central metabolic regulator of blood glucose.

 Stores glucose as glycogen (approx. 100–120 g).

 Releases glucose during fasting via glycogenolysis and


gluconeogenesis.

 Acts as a glucose buffer — takes up excess glucose after meals and


releases it during fasting.

b) Skeletal Muscle

 Stores glycogen for internal energy needs (approx. 300–400 g).


 Utilizes glucose for ATP production during activity.

 Does not release glucose into the bloodstream due to absence of


glucose-6-phosphatase.

c) Adipose Tissue

 Converts excess glucose into fatty acids (lipogenesis).

 During fasting, releases free fatty acids and glycerol for energy and
gluconeogenesis.

d) Pancreas

 Contains islets of Langerhans, which secrete key regulatory hormones:

o β-cells → Insulin

o α-cells → Glucagon

o δ-cells → Somatostatin

o PP cells → Pancreatic polypeptide

e) Brain

 Cannot store glucose or use fatty acids effectively.

 Depends entirely on constant glucose supply from the bloodstream.

5. Hormonal Regulation of Blood Glucose

Blood glucose is primarily regulated by the antagonistic actions of


insulin and glucagon, supported by several other hormones.

A. Insulin (Hypoglycemic Hormone)

 Source: β-cells of pancreatic islets

 Chemical nature: Peptide hormone (51 amino acids)


 Half-life: ~6 minutes in circulation

 Main function: Decreases blood glucose levels

Mechanism of Action

1. Promotes glucose uptake into muscle and adipose tissue via GLUT4
transporters.

2. Stimulates glycogenesis in liver and muscles.

3. Enhances lipogenesis — conversion of glucose to fatty acids in adipose


tissue.

4. Inhibits gluconeogenesis and glycogenolysis in the liver.

5. Stimulates protein synthesis and inhibits protein degradation.

Overall Effect:

↓ Blood glucose level (by increasing uptake and storage, and reducing
production)

Stimuli for Secretion

 Elevated blood glucose (primary stimulus)

 Increased amino acids after a meal

 Gastrointestinal hormones (incretins: GLP-1, GIP)

 Parasympathetic stimulation (vagal activity)

Inhibitors

 Epinephrine

 Cortisol

 Sympathetic stimulation
B. Glucagon (Hyperglycemic Hormone)

 Source: α-cells of pancreatic islets

 Chemical nature: Peptide hormone (29 amino acids)

 Main function: Increases blood glucose levels

Mechanism of Action

1. Stimulates glycogenolysis — breakdown of glycogen to glucose in liver.

2. Activates gluconeogenesis — glucose synthesis from amino acids and


lactate.

3. Promotes lipolysis — breakdown of fats to fatty acids.

4. Inhibits glycogenesis.

Overall Effect:

↑ Blood glucose level (by increasing glucose release and synthesis)

Stimuli for Secretion

 Low blood glucose levels

 High blood amino acid levels

 Exercise

 Sympathetic stimulation

6. Metabolic States and Glucose Regulation

A. Fed State (Postprandial State)

Occurs after eating when glucose is absorbed from the intestine.

 High blood glucose → Insulin secretion ↑, Glucagon ↓


 Metabolic events:

o Glucose uptake by tissues (muscle, fat)

o Glycogen synthesis (liver, muscle)

o Lipid synthesis (adipose tissue)

o Protein synthesis

 End result: Lowering of blood glucose to normal range.

B. Fasting State (Post-absorptive State)

Occurs several hours after eating.

 Low blood glucose → Glucagon ↑, Insulin ↓

 Metabolic events:

o Glycogen breakdown (glycogenolysis)

o Glucose synthesis (gluconeogenesis)

o Lipolysis for energy

 End result: Maintenance of normal blood glucose.

7. Neural Regulation of Glucose

The autonomic nervous system plays a supporting role:

 Sympathetic stimulation: Promotes glucose release via adrenaline.

 Parasympathetic stimulation: Enhances insulin secretion during rest


and digestion.

The hypothalamus also monitors blood glucose and modulates appetite and
endocrine signals accordingly.
8. Feedback Mechanism of Glucose Regulation

Blood glucose regulation operates through a negative feedback loop:

1. When blood glucose rises:

o β-cells secrete insulin.

o Glucose uptake by cells increases.

o Liver stores glucose as glycogen.

o Blood glucose returns to normal.

o Insulin secretion decreases.

2. When blood glucose falls:

o α-cells secrete glucagon.

o Liver releases glucose via glycogenolysis and gluconeogenesis.

o Blood glucose rises to normal.

o Glucagon secretion decreases.

This dynamic equilibrium maintains glucose homeostasis continuously.

9. Pathophysiological Aspects

a) Hyperglycemia

 Prolonged high glucose levels.

 Seen in diabetes mellitus (Type 1 or Type 2).

 Causes oxidative stress, endothelial damage, and organ complications.

b) Hypoglycemia

 Abnormally low glucose levels (<70 mg/dL).


 Causes confusion, dizziness, sweating, and may lead to seizures or coma.

 Often due to insulin overdose or missed meals.

c) Insulin Resistance

 Target cells fail to respond to insulin.

 Leads to Type 2 diabetes mellitus.

Obesity

Obesity, a condition marked by abnormal or excessive fat accumulation,


is a global health challenge with serious implications for morbidity, mortality,
and healthcare systems. It is commonly assessed using the Body Mass Index
(BMI), where a BMI of ≥30 kg/m² classifies an individual as obese. However,
obesity is more than a simple measure of body weight; it represents a complex
interplay of genetic, environmental, behavioral, and biological factors that
disrupt energy homeostasis and metabolic health.

Causes of Obesity

Obesity arises when caloric intake consistently exceeds energy


expenditure, leading to fat storage in adipose tissue. However, the drivers of
this energy imbalance extend beyond simple overeating and inactivity.

1. Dietary Factors

Diet plays a central role in obesity development through its influence on energy
intake, satiety regulation, and metabolic processes.

 High-Calorie Diets:

o Consuming energy-dense foods rich in fats, sugars, and refined


carbohydrates leads to a positive energy balance, where caloric
intake surpasses caloric expenditure.
o Fast food, sugary beverages, and processed snacks are common
culprits, delivering excessive calories without providing satiety.

 Low Protein and Fiber Diets:

o Protein and fiber play critical roles in satiety signaling. Protein


influences hunger hormones like ghrelin and peptide YY, reducing
appetite, while fiber slows gastric emptying and enhances feelings
of fullness.

o Diets lacking these components fail to trigger adequate satiety


responses, encouraging overeating.

2. Physical Inactivity

Modern lifestyles characterized by sedentary behavior contribute significantly


to obesity.

 Inadequate Physical Activity:

o Insufficient physical activity reduces energy expenditure,


facilitating fat accumulation.

o Physical inactivity also diminishes the ability of skeletal muscles to


oxidize fats, leading to metabolic inflexibility—a reduced capacity
to switch between using fats and carbohydrates for energy.

 Sedentary Behavior:

o Prolonged sitting or inactivity decreases glucose uptake by muscle


cells, promoting insulin resistance.

o Sedentary lifestyles are closely linked to increased visceral fat,


which has profound metabolic implications.

3. Stress and Psychological Factors


Stress and psychological influences play a pivotal role in promoting behaviors
and physiological changes that contribute to obesity.

 Emotional Eating:

o Chronic stress triggers the release of cortisol, a glucocorticoid


hormone that enhances the desire for high-calorie, energy-dense
"comfort foods."

o Emotional distress often leads to overeating as a coping


mechanism, perpetuating weight gain.

 Cortisol and Fat Deposition:

o Elevated cortisol levels stimulate lipogenesis (fat storage) in the


abdominal region, resulting in central obesity.

o Chronic cortisol exposure disrupts the hypothalamic-pituitary-


adrenal (HPA) axis, further amplifying stress-related weight gain.

4. Sleep Deprivation

Sleep is a crucial regulator of metabolic health. Sleep deprivation has profound


effects on hunger and energy balance.

 Hormonal Disruption:

o Sleep deprivation decreases leptin (a hormone that signals satiety)


and increases ghrelin (a hormone that stimulates hunger), leading
to heightened appetite.

o This hormonal imbalance results in cravings for high-calorie,


carbohydrate-rich foods.

 Impact on Glucose Metabolism:


o Lack of sleep impairs insulin sensitivity, promoting hyperglycemia
and increased fat storage.

o Sleep deprivation disrupts circadian rhythms, which play a role in


regulating energy metabolism.

5. Genetic and Epigenetic Factors

Obesity has a significant genetic component, modulated by environmental and


lifestyle factors.

 Genetic Predisposition:

o Certain genes influence appetite control, basal metabolic rate


(BMR), and fat distribution. For instance, mutations in the FTO (fat
mass and obesity-associated) gene are associated with increased
food intake and adiposity.

o Polygenic obesity results from the combined effects of multiple


genetic variations that subtly influence weight regulation.

 Epigenetic Modifications:

o Environmental exposures, such as poor diet or maternal


malnutrition during pregnancy, can induce epigenetic changes that
alter gene expression.

o These modifications affect metabolic pathways, appetite control,


and energy balance, increasing the risk of obesity in future
generations.

Biological Mechanisms in Obesity Development

The biological underpinnings of obesity involve a combination of


hormonal dysregulation, adipose tissue dysfunction, and chronic inflammation,
all of which perpetuate weight gain and metabolic disturbances.
1. Adipokine Imbalance

Adipose tissue is not merely a fat storage organ; it functions as an endocrine


organ, secreting adipokines (signaling molecules) that regulate appetite,
metabolism, and inflammation.

 Leptin Resistance:

o Leptin, produced by adipocytes, signals the hypothalamus to


reduce food intake and increase energy expenditure.

o In obesity, elevated leptin levels (due to increased fat mass) fail to


suppress appetite—a condition termed leptin resistance.

o This resistance disrupts energy homeostasis, leading to persistent


overeating and weight gain.

 Reduced Adiponectin:

o Adiponectin enhances insulin sensitivity, promotes lipid oxidation,


and reduces inflammation.

o In obesity, adiponectin levels are significantly reduced,


contributing to insulin resistance, dyslipidemia, and metabolic
syndrome.

2. Chronic Low-Grade Inflammation

Obesity is associated with a state of chronic, low-grade systemic inflammation


that contributes to metabolic dysfunction.

 Role of Adipose Tissue:

o Excess adipose tissue, particularly visceral fat, recruits and


activates immune cells, such as macrophages.
o These immune cells release pro-inflammatory cytokines like tumor
necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6).

 Impact on Insulin Sensitivity:

o Inflammatory cytokines interfere with insulin signaling pathways,


leading to insulin resistance—a precursor to type 2 diabetes.

o Chronic inflammation also damages endothelial cells, increasing


the risk of cardiovascular diseases.

 Oxidative Stress:

o Excess fat accumulation enhances the production of reactive


oxygen species (ROS), which exacerbate cellular damage and
further perpetuate inflammation.

3. Neuroendocrine Dysregulation

Obesity involves disruptions in neuroendocrine signaling pathways that


regulate hunger, satiety, and energy balance.

 Hypothalamic Dysfunction:

o The hypothalamus integrates signals from leptin, ghrelin, and


insulin to regulate appetite. In obesity, hypothalamic inflammation
impairs these regulatory mechanisms.

o This leads to heightened hunger and decreased satiety,


perpetuating overeating.

 Insulin Resistance:

o Insulin, beyond its role in glucose regulation, suppresses appetite


by acting on the hypothalamus.
o Insulin resistance in obesity weakens this feedback mechanism,
contributing to increased caloric intake.

Paediatric and Adolescent Obesity

Definition

 Paediatric and adolescent obesity means having excess body fat in


children (paediatric) and teenagers (adolescents), which can
negatively affect their health, growth, and development.

 It is usually diagnosed by comparing a child’s Body Mass Index (BMI)


with standard growth charts for their age and sex.

Meaning of Weight Control

1. Definition

Weight control means maintaining a healthy body weight through a balance


between:

 Energy intake (food consumed) and

 Energy expenditure (physical activity and metabolism).

In the context of paediatric and adolescent obesity, it refers to helping


children:

 Prevent further weight gain, or

 Gradually achieve a healthier weight while continuing to grow


normally.

2. Key Principles of Weight Control

Strategy Description
Eat more fruits, vegetables, whole grains, and lean
Healthy Diet
proteins. Reduce sugar, fried, and processed foods.
Regular Physical At least 60 minutes of moderate-to-vigorous exercise
Activity daily (sports, walking, cycling).
Limit screen time (<2 hours/day), encourage outdoor
Behavioral Change
play, family meals, and adequate sleep.
Strategy Description
Psychological
Address emotional issues and boost self-esteem.
Support
Family & School Parents, teachers, and healthcare providers should
Involvement work together to promote healthy habits.

3. Goal of Weight Control in Children

Unlike adults, the goal is often not rapid weight loss, but:

 Slowing weight gain as the child continues to grow in height,


so that the BMI percentile gradually shifts toward normal.

4. Importance

Effective weight control in childhood and adolescence:

 Prevents long-term obesity-related diseases (heart disease, diabetes,


etc.)
 Improves mental and emotional health
 Builds lifelong healthy habits

Health Indices

Health indices are tools that quantify health-related data to help evaluate
and monitor the overall health status of individuals or populations. They can
assist in identifying health trends, assessing the nutritional and disease risk
status, and guiding public health interventions. These indices are essential for
health professionals, policymakers, and researchers, offering a simple,
measurable way to track various health factors and their impacts.

1. Definition and Importance

A health index is a composite measure designed to quantify health-


related factors and serve as an indicator of the health status of individuals or
populations. These indices can include both direct measures of health, such as
body measurements or disease rates, and indirect measures like lifestyle
factors, behaviors, and environmental conditions.

The importance of health indices lies in their ability to:

 Assess health risks: By providing objective measurements of health


factors (like body fat, blood pressure, or diet quality), these indices help
assess the risk of diseases such as obesity, heart disease, diabetes, and
hypertension.

 Guide public health interventions: Health indices provide a basis for


planning and implementing public health policies and interventions,
particularly in targeting populations at high risk for specific conditions.

 Monitor population health trends: Health indices are used to observe


changes in the health status of populations over time, helping identify
emerging health problems or improvements in public health.

 Support personalized health care: In clinical settings, health indices


help tailor interventions to individual needs, such as weight
management, nutritional counseling, and disease prevention strategies.

Body Mass Index (BMI)

1. Introduction

Body Mass Index (BMI) is one of the most widely used tools to assess
body fatness and weight status in individuals.
It provides a simple, quick, and cost-effective method to identify whether a
person is underweight, normal, overweight, or obese.
2. Definition

Body Mass Index (BMI) is a numerical value that represents the


relationship between a person’s weight and height. It is used as an indirect
measure of body fat.

3. Formula

4. BMI Classification (Adults)

Category BMI Range (kg/m²) Health Risk

Nutritional deficiency,
Underweight < 18.5
osteoporosis

Normal (Healthy
18.5 – 24.9 Lowest risk
weight)

Overweight 25.0 – 29.9 Moderate risk

Obesity Class I 30.0 – 34.9 High risk

Obesity Class II 35.0 – 39.9 Very high risk

Obesity Class III


≥ 40 Extremely high risk
(Severe/Morbid)

5. BMI Classification for Children and Adolescents

Since children’s body composition changes with age and differs by sex,
BMI is interpreted using age- and sex-specific percentile charts (CDC or
WHO).
Category Percentile Range

Underweight < 5th percentile

Normal weight 5th – 84th percentile

Overweight 85th – 94th percentile

Obese ≥ 95th percentile

6. Uses of BMI

 Screening tool to assess weight categories that may lead to health


problems.

 Public health indicator for assessing obesity trends in populations.

 Clinical tool for guiding weight management and nutrition programs.

 Used in research to study relationships between weight, disease risk,


and mortality.

7. Advantages of BMI

 Simple and non-invasive – requires only height and weight.

 Low cost – no specialized equipment needed.

 Correlates moderately with body fat percentage.


Useful for large-scale epidemiological studies.

8. Limitations of BMI

 Does not differentiate between fat and muscle mass:

o A muscular person may have a high BMI but low body fat.

 Does not consider fat distribution:

o Central (abdominal) obesity has higher health risk even with


normal BMI.

 Age and sex differences:


o BMI interpretation differs for children, adults, and older adults.

 Ethnic variation:

o Health risks occur at lower BMI values in Asians than in Western


populations.

You might also like